315 related articles for article (PubMed ID: 21212412)
1. miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation.
Sun D; Lee YS; Malhotra A; Kim HK; Matecic M; Evans C; Jensen RV; Moskaluk CA; Dutta A
Cancer Res; 2011 Feb; 71(4):1313-24. PubMed ID: 21212412
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-99b-5p targets mTOR/AR axis, induces autophagy and inhibits prostate cancer cell proliferation.
Niture S; Tricoli L; Qi Q; Gadi S; Hayes K; Kumar D
Tumour Biol; 2022; 44(1):107-127. PubMed ID: 35811549
[TBL] [Abstract][Full Text] [Related]
3. miR-183 in prostate cancer cells positively regulates synthesis and serum levels of prostate-specific antigen.
Larne O; Östling P; Haflidadóttir BS; Hagman Z; Aakula A; Kohonen P; Kallioniemi O; Edsjö A; Bjartell A; Lilja H; Lundwall Å; Ceder Y
Eur Urol; 2015 Oct; 68(4):581-8. PubMed ID: 25556023
[TBL] [Abstract][Full Text] [Related]
4. Identification and Functional Validation of Reciprocal microRNA-mRNA Pairings in African American Prostate Cancer Disparities.
Wang BD; Ceniccola K; Yang Q; Andrawis R; Patel V; Ji Y; Rhim J; Olender J; Popratiloff A; Latham P; Lai Y; Patierno SR; Lee NH
Clin Cancer Res; 2015 Nov; 21(21):4970-84. PubMed ID: 26089375
[TBL] [Abstract][Full Text] [Related]
5. Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells.
Sun D; Layer R; Mueller AC; Cichewicz MA; Negishi M; Paschal BM; Dutta A
Oncogene; 2014 Mar; 33(11):1448-57. PubMed ID: 23503464
[TBL] [Abstract][Full Text] [Related]
6. The role of micro RNAs let7c, 100 and 218 expression and their target RAS, C-MYC, BUB1, RB, SMARCA5, LAMB3 and Ki-67 in prostate cancer.
Reis ST; Timoszczuk LS; Pontes-Junior J; Viana N; Silva IA; Dip N; Srougi M; Leite KR
Clinics (Sao Paulo); 2013 May; 68(5):652-7. PubMed ID: 23778407
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor microRNAs, miR-100 and -125b, are regulated by 1,25-dihydroxyvitamin D in primary prostate cells and in patient tissue.
Giangreco AA; Vaishnav A; Wagner D; Finelli A; Fleshner N; Van der Kwast T; Vieth R; Nonn L
Cancer Prev Res (Phila); 2013 May; 6(5):483-94. PubMed ID: 23503652
[TBL] [Abstract][Full Text] [Related]
8. Epigallocatechin-3-gallate Enhances the Efficacy of MicroRNA-34a Mimic and MicroRNA-93 Inhibitor Co-transfection in Prostate Cancer Cell Line.
Mokhtari H; Yaghmaei B; Sirati-Sabet M; Jafari N; Mardomi A; Abediankenari S; Mahrooz A
Iran J Allergy Asthma Immunol; 2020 Dec; 19(6):612-623. PubMed ID: 33463130
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma.
Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA
Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139
[TBL] [Abstract][Full Text] [Related]
10. Nm23-H1 inhibits lung cancer bone-specific metastasis by upregulating miR-660-5p targeted SMARCA5.
Ai C; Ma G; Deng Y; Zheng Q; Gen Y; Li W; Li Y; Zu L; Zhou Q
Thorac Cancer; 2020 Mar; 11(3):640-650. PubMed ID: 32022430
[TBL] [Abstract][Full Text] [Related]
11. The microRNA profile of prostate carcinoma obtained by deep sequencing.
Szczyrba J; Löprich E; Wach S; Jung V; Unteregger G; Barth S; Grobholz R; Wieland W; Stöhr R; Hartmann A; Wullich B; Grässer F
Mol Cancer Res; 2010 Apr; 8(4):529-38. PubMed ID: 20353999
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of miRNA expression profiles for prostate cancer recurrence following radical prostatectomy.
Pashaei E; Pashaei E; Ahmady M; Ozen M; Aydin N
PLoS One; 2017; 12(6):e0179543. PubMed ID: 28651018
[TBL] [Abstract][Full Text] [Related]
13. Androgen-regulated miR-32 targets BTG2 and is overexpressed in castration-resistant prostate cancer.
Jalava SE; Urbanucci A; Latonen L; Waltering KK; Sahu B; Jänne OA; Seppälä J; Lähdesmäki H; Tammela TL; Visakorpi T
Oncogene; 2012 Oct; 31(41):4460-71. PubMed ID: 22266859
[TBL] [Abstract][Full Text] [Related]
14. The chromatin remodeling factor SRCAP modulates expression of prostate specific antigen and cellular proliferation in prostate cancer cells.
Slupianek A; Yerrum S; Safadi FF; Monroy MA
J Cell Physiol; 2010 Aug; 224(2):369-75. PubMed ID: 20432434
[TBL] [Abstract][Full Text] [Related]
15. gga-miR-99a targets SMARCA5 to regulate Mycoplasma gallisepticum (HS strain) infection by depressing cell proliferation in chicken.
Zhao Y; Wang Z; Hou Y; Zhang K; Peng X
Gene; 2017 Sep; 627():239-247. PubMed ID: 28652181
[TBL] [Abstract][Full Text] [Related]
16. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
17. Circ-SMARCA5 suppresses progression of multiple myeloma by targeting miR-767-5p.
Liu H; Wu Y; Wang S; Jiang J; Zhang C; Jiang Y; Wang X; Hong L; Huang H
BMC Cancer; 2019 Oct; 19(1):937. PubMed ID: 31601173
[TBL] [Abstract][Full Text] [Related]
18. Characterization and Evidence of the miR-888 Cluster as a Novel Cancer Network in Prostate.
Hasegawa T; Glavich GJ; Pahuski M; Short A; Semmes OJ; Yang L; Galkin V; Drake R; Esquela-Kerscher A
Mol Cancer Res; 2018 Apr; 16(4):669-681. PubMed ID: 29330297
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the glucocorticoid receptor results in an enhanced miR-99a/100-mediated radiation response in stem-like cells from human prostate cancers.
Rane JK; Erb HH; Nappo G; Mann VM; Simms MS; Collins AT; Visakorpi T; Maitland NJ
Oncotarget; 2016 Aug; 7(32):51965-51980. PubMed ID: 27340920
[TBL] [Abstract][Full Text] [Related]
20. miR-15b-5p facilitates the tumorigenicity by targeting RECK and predicts tumour recurrence in prostate cancer.
Chen R; Sheng L; Zhang HJ; Ji M; Qian WQ
J Cell Mol Med; 2018 Mar; 22(3):1855-1863. PubMed ID: 29363862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
